Wells Fargo Maintains Equal-Weight on Ironwood Pharmaceuticals, Raises Price Target to $5
Benzinga Newsdesk 10 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Equal-Weight and raises the price target from $3 to $5.
Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Equal-Weight and raises the price target from $3 to $5.